DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Biocon Limited — Appointment

NSE 2 hrs ago·6 Aug 2026, 3:29 pm

Biocon

Biocon Limited has announced the re-appointment of Mr. Erick Mazumdar as a Non-Executive Director, effective from August 6, 2026. This move ensures continuity in the company's leadership and strategic direction as he extends his tenure by another term.

For investors, this news signals stability and confidence in the company's existing management team. It suggests that the board values Mazumdar's experience and contribution to Biocon's growth, which can be reassuring for those tracking the stock's long-term performance.

Investors should watch for any further disclosures regarding the board's composition and upcoming strategic decisions. The re-appointment underscores the company's focus on maintaining its current leadership structure as it navigates future business challenges.